Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

21
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
21
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

25
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
25
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

23
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
23
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

17
During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
17
Peripheral Artery Disease IV: Nursing Management01:26

Peripheral Artery Disease IV: Nursing Management

24
 The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses,...
24
这页已由机器翻译。其他页面可能仍然显示为英文。View in English
  1. 首页
  2. 研究领域
  3. 生物医学和临床科学
  4. 心血管医学和血液学
  5. 心脏病 (包括心血管疾病)
  6. 药物除支架与裸体金属支架在症状性骨髓关节动脉疾病中的有效性:eminent随机试验的主要结果

药物除支架与裸体金属支架在症状性骨髓关节动脉疾病中的有效性:EMINENT随机试验的主要结果

Yann Gouëffic1, Giovanni Torsello2, Thomas Zeller3

  • 1Groupe Hospitalier Paris St. Joseph, Department of Vascular and Endovascular Surgery, Paris, France (Y.G.).

Circulation
|October 18, 2022

相关实验视频

Murine Model of Femoral Artery Wire Injury with Implantation of a Perivascular Drug Delivery Patch
07:05

Murine Model of Femoral Artery Wire Injury with Implantation of a Perivascular Drug Delivery Patch

Published on: February 10, 2015

18.2K
Reduction of Radiation Exposure during Endovascular Treatment of Peripheral Arterial Disease Combining Fiber Optic RealShape Technology and Intravascular Ultrasound
13:48

Reduction of Radiation Exposure during Endovascular Treatment of Peripheral Arterial Disease Combining Fiber Optic RealShape Technology and Intravascular Ultrasound

Published on: April 21, 2023

1.6K
A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
04:30

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

25.6K

在PubMed 上查看摘要

概括
此摘要是机器生成的。

在12个月的EMINENT研究中,药物释放支架 (DES) 与裸体金属支架 (BMS) 相比显著改善了患者的初级通透性.

科学领域:

  • 心血管医学
  • 干预心脏病学
  • 血管外科

背景情况:

  • 药物释放支架 (DES) 与裸金属支架 (BMS) 在股骨周围动脉疾病 (PAD) 中的益处尚不清楚.
  • 这项EMINENT研究旨在将Eluvia DES与BMS进行PAD治疗.

研究的目的:

  • 评估Eluvia DES与BMS在股骨损伤中的初级通透性.
  • 评估持续的临床改善,生活质量和行走功能作为次要结果.

主要方法:

  • 一个前性的,随机的,受控的,多中心的欧洲试验,盲目参与者和结果评估.
  • 775名患有症状的PAD患者被随机分为2:1的Eluvia DES或BMS.
  • 主要终点是12个月的初级通透性,通过双重超声检查和没有再血管化/ 绕道检查来确定.

主要成果:

  • 与BMS (74. 3%) 相比,DES的12个月初级通透率显著更高 (P< 0. 01).
  • 主要持续的临床改善在DES组中也较大 (83. 0%与76. 6%,P=0. 045).
  • 在12个月后,两组之间没有观察到任何原因的死亡率显著差异.

结论:

关键词:
药物释放的支架血管内科手术帕克利塔塞尔周围动脉疾病

相关实验视频

Murine Model of Femoral Artery Wire Injury with Implantation of a Perivascular Drug Delivery Patch
07:05

Murine Model of Femoral Artery Wire Injury with Implantation of a Perivascular Drug Delivery Patch

Published on: February 10, 2015

18.2K
Reduction of Radiation Exposure during Endovascular Treatment of Peripheral Arterial Disease Combining Fiber Optic RealShape Technology and Intravascular Ultrasound
13:48

Reduction of Radiation Exposure during Endovascular Treatment of Peripheral Arterial Disease Combining Fiber Optic RealShape Technology and Intravascular Ultrasound

Published on: April 21, 2023

1.6K
A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
04:30

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

25.6K
  • 在EMINENT研究中,使用聚合物基的帕克利塔塞尔排泄支架显示出优异的1年初级通透性.
  • 这些结果支持使用Eluvia DES作为关节动脉病变的第一线治疗.